Article Name Global/International
With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage.
31st July, 2025
Milestone underscores ClariMed’s commitment to quality excellence and reinforces its position as a trusted partner in navigating complex global regulatory landscapes
30th July, 2025
Strategic collaboration aims to accelerate validation and commercialisation of non-invasive tests, enabling earlier, more accessible diagnosis of Alzheimer’s disease
30th July, 2025
Strategic relocation from Hong Kong strengthens ties to Asia’s thriving MedTech ecosystem, enhances collaboration with global partners, and supports ambitious expansion plans
30th July, 2025
AI-powered, patient-matched solution aims to simplify Lapidus procedures and enhance surgical outcomes
30th July, 2025
Partnership aims for CAP/CLIA certification of organoid-based assay to guide patient-specific treatment decisions; $10 million investment to fuel clinical validation across multiple cancer types
30th July, 2025
By aligning regulatory rigour with technological complexity, the FDA safeguards public health while accelerating access to life-changing medical innovations through adaptive pathways and total lifecycle vigilance
30th July, 2025
First camera-agnostic motion tracking solution for laparoscopic surgery delivers real-time insight into surgical technique and proficiency across all devices and operating rooms
30th July, 2025
First and only purpose-built solution delivering rapid and complete luminal clot removal in small vessel and arteriovenous access cases
30th July, 2025
First in the industry to achieve dual certification for both reagents and analysers within its Atellica portfolio
30th July, 2025
Developed with PacBio's PureTarget technology, the new test enhances identification of complex DNA repeat expansions to support accurate diagnosis and care for patients with neurological disorders
30th July, 2025
New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness.
29th July, 2025
Breakthrough findings for QyScore® and QyPredict® highlight enhanced accuracy in brain segmentation and early identification of cognitive decline, paving the way for improved clinical trials and patient outcomes in Alzheimer’s disease.
29th July, 2025
New magnetic ablation catheter designed to enhance precision and reach in robotic electrophysiology procedures across the U.S.
28th July, 2025
Launched at AAIC 2025, the ultra-sensitive assays aim to improve early detection, disease monitoring, and biomarker discovery in neurodegenerative research.
28th July, 2025
Collaboration aims to streamline cardiac data workflows and enhance clinical decision-making through seamless EHR integration.
28th July, 2025
New solution aims to enhance workflow efficiency, image quality, and accessibility in busy hospitals and diagnostic centers worldwide.
28th July, 2025
Collaboration aims to develop next-generation endoluminal robotic platforms for enhanced precision and minimally invasive interventions in gastrointestinal care.
25th July, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer